Patient details
Full identifiers, age, sex, weight when relevant, and medical record number to match the report with clinical charts and medication administration records.
Recording adverse reactions preserves patient safety data, supports appropriate clinical follow-up, and creates a defensible record for regulatory or payer review.
Clinicians and risk managers complete and review adverse reaction reports as part of clinical care and safety oversight.
Accurate routing ensures clinical teams, patient records, and reporting workflows receive required information for follow-up and regulatory compliance.
| Field | Configuration |
|---|---|
| Required Patient Fields | Make MRN, name, and DOB mandatory. |
| Conditional Sections | Show device fields only if device selected as suspected product. |
| Routing Rules | Auto-send severe cases to risk mgmt and patient safety lead. |
| Audit Trail | Enable timestamped activity log for every edit and signature. |
Ensure the signing and storage platform meets healthcare privacy, authentication, and interoperability needs.
Full identifiers, age, sex, weight when relevant, and medical record number to match the report with clinical charts and medication administration records.
Precise time stamps for exposure, symptom onset, interventions, and resolution to support temporal association and causality assessment.
Complete product name, manufacturer, lot/serial number, route, dose, and administration setting to enable manufacturer follow-up and batch investigation.
Concise narrative of signs, objective findings, diagnostic workup, treatments given, and response to interventions for clinical reviewers and regulators.
Name, role, contact details, and facility so follow-up questions can be answered without delays or anonymous submissions.
Severity classification, whether submitted externally (e.g., FDA MedWatch), and any immediate patient safety actions taken or recommended.
Medication administration records, pharmacy dispensing logs, and prescription orders that show timing and dose relative to the adverse event.
Relevant progress notes, nursing notes, emergency department documentation, and discharge summaries that describe the clinical course and interventions.
Relevant lab results, imaging reports, and objective measures that support the clinical description and rule out alternatives.
Device identifiers, implant records, procedure notes, and any device interrogation logs when a device is implicated.
If the event is life-threatening, document and escalate immediately; clinical care comes first, reporting follows.
Follow facility policy—many require submission within 24–72 hours of recognition.
Notify manufacturer per their complaint handling timelines, often within days of identification.
Submit to federal or state agencies when statutory thresholds are met; timelines vary by agency and incident type.
Retain the report and attachments according to applicable retention schedules and legal requirements.
| Criteria | Healthcare Adverse Reactions Report | Product Complaint Form |
|---|---|---|
| Primary Purpose | clinical safety data | manufacturer quality tracking |
| Regulatory Trigger | yes — may require agency notice | sometimes — per manufacturer policy |
| PHI Included | often redacted or summary | |
| Attachment Needs | high — labs/notes | moderate — purchase/inspection records |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by plan | Varies by plan | Varies by plan | Varies by plan |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |
A hospitalized patient developed anaphylaxis within 30 minutes of medication administration, requiring epinephrine and ICU transfer.
Within 48 hours, a patient reported high fever and seizure after vaccination.
The attending physician often certifies the clinical facts and outcome; their signature attributes clinical opinion and may be required for regulatory submissions or insurer reviews.
A designated risk management official can complete administrative sections, attest to internal review, and forward the report to external agencies or manufacturers as appropriate.